Gala B, Laurel S, Sohail HM, Mariana N, et al. Phase 1b randomized controlled study of short course topical recombinant human nerve growth factor (rhNGF) for neuroenhancement in glaucoma: safety, tolerability and efficacy measure outcomes. Am J Ophthalmol 2021 Nov 12. pii: S0002-9394(21)00578.
PMID: 34780798